OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The challenge of drug resistance in cancer treatment: a current overview
Michail Nikolaou, Athanasia Pavlopoulou, Alexandros G. Georgakilas, et al.
Clinical & Experimental Metastasis (2018) Vol. 35, Iss. 4, pp. 309-318
Closed Access | Times Cited: 488

Showing 1-25 of 488 citing articles:

Polymeric micelles in cancer therapy: State of the art
Balaram Ghosh, Swati Biswas
Journal of Controlled Release (2021) Vol. 332, pp. 127-147
Closed Access | Times Cited: 414

Chemoresistance mechanisms of breast cancer and their countermeasures
Xiwei Ji, Yuan Lü, Huifang Tian, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 114, pp. 108800-108800
Open Access | Times Cited: 295

Polytherapy and Targeted Cancer Drug Resistance
Nilanjana Chatterjee, Trever G. Bivona
Trends in cancer (2019) Vol. 5, Iss. 3, pp. 170-182
Open Access | Times Cited: 234

Overcoming cancer chemotherapy resistance by the induction of ferroptosis
Yumin Wang, Xiaorui Wu, Ren Zhao, et al.
Drug Resistance Updates (2022) Vol. 66, pp. 100916-100916
Closed Access | Times Cited: 168

Very low intensity ultrasounds as a new strategy to improve selective delivery of nanoparticles-complexes in cancer cells
Rossella Loria, Claudia Giliberti, Angelico Bedini, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 159

Therapeutic strategies to overcome taxane resistance in cancer
Tuyelee Das, Uttpal Anand, Swaroop Kumar Pandey, et al.
Drug Resistance Updates (2021) Vol. 55, pp. 100754-100754
Closed Access | Times Cited: 159

Skin cancer biology and barriers to treatment: Recent applications of polymeric micro/nanostructures
Nazeer Hussain Khan, Maria Mir, Lei Qian, et al.
Journal of Advanced Research (2021) Vol. 36, pp. 223-247
Open Access | Times Cited: 147

Novel nanomedicines to overcome cancer multidrug resistance
Zhenwei Su, Shaowei Dong, Shan‐Chao Zhao, et al.
Drug Resistance Updates (2021) Vol. 58, pp. 100777-100777
Closed Access | Times Cited: 137

Targeting Drug Chemo-Resistance in Cancer Using Natural Products
Wamidh H. Talib, Ahmad R. Alsayed, Muna Barakat, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1353-1353
Open Access | Times Cited: 137

The role of polyphenols in overcoming cancer drug resistance: a comprehensive review
Parisa Maleki Dana, Fatemeh Sadoughi, Zatollah Asemi, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 131

Current therapy and drug resistance in metastatic castration-resistant prostate cancer
Maoping Cai, Xian‐Lu Song, Xinan Li, et al.
Drug Resistance Updates (2023) Vol. 68, pp. 100962-100962
Open Access | Times Cited: 126

TranSynergy: Mechanism-driven interpretable deep neural network for the synergistic prediction and pathway deconvolution of drug combinations
Qiao Liu, Lei Xie
PLoS Computational Biology (2021) Vol. 17, Iss. 2, pp. e1008653-e1008653
Open Access | Times Cited: 124

Targeted Delivery of Drugs and Genes Using Polymer Nanocarriers for Cancer Therapy
Wentao Xia, Zixuan Tao, Bin Zhu, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9118-9118
Open Access | Times Cited: 113

Targeting Energy Metabolism in Cancer Stem Cells: Progress and Challenges in Leukemia and Solid Tumors
Courtney L. Jones, Anagha Inguva, Craig T. Jordan
Cell stem cell (2021) Vol. 28, Iss. 3, pp. 378-393
Open Access | Times Cited: 111

STAT3 pathway in cancers: Past, present, and future
Hanqi Wang, Qi‐Wen Man, Fang‐Yi Huo, et al.
MedComm (2022) Vol. 3, Iss. 2
Open Access | Times Cited: 107

Unveiling the mechanisms and challenges of cancer drug resistance
Sameer Ullah Khan, Kaneez Fatima, Shariqa Aisha, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 101

Triggered azobenzene-based prodrugs and drug delivery systems
Jundong Zhu, Tao Guo, Zheng Wang, et al.
Journal of Controlled Release (2022) Vol. 345, pp. 475-493
Closed Access | Times Cited: 85

Heat Shock Proteins and HSF1 in Cancer
Anna M. Cyran, Anatoly Zhitkovich
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 72

Cancer chemotherapy resistance: Mechanisms and recent breakthrough in targeted drug delivery
Fatemeh Davodabadi, Seyedeh Fatemeh Sajjadi, Mohammad Sarhadi, et al.
European Journal of Pharmacology (2023) Vol. 958, pp. 176013-176013
Closed Access | Times Cited: 58

Nanotechnology-empowered strategies in treatment of skin cancer
Jyoti Chandra, Nazeer Hasan, Nazim Nasir, et al.
Environmental Research (2023) Vol. 235, pp. 116649-116649
Closed Access | Times Cited: 44

Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response
Nasim Ebrahimi, Mahdokht Sadat Manavi, Ferdos Faghihkhorasani, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 1, pp. 457-479
Closed Access | Times Cited: 27

Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive Review
Nilesh Kumar Sharma, Anjali Bahot, Gopinath Sekar, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 680-680
Open Access | Times Cited: 16

Anti-cancer effect of gallic acid in presence of low level laser irradiation: ROS production and induction of apoptosis and ferroptosis
Khatereh Khorsandi, Zahra Kianmehr, Zohreh hosseinmardi, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 127

Page 1 - Next Page

Scroll to top